KEY INTERVIEW: The Remarkable Anti-Ageing Possibilities for New Supplement Discovered by Canadian Researchers

636059219531270775lemon-1.jpg

08 Aug 2016 --- A dietary supplement packed with a blend of 30 natural vitamins and minerals has shown remarkable anti-ageing properties that can prevent and even reverse brain cell loss.

That is the assertion from a team of researchers in the department of biology at McMaster University in Ontario, Canada. The mixture of natural ingredients, all of which are easily accessible from health stores, could someday slow down the progression of neurological diseases like Alzheimer’s, Parkinson’s and amyotrophic lateral sclerosis (ALS).

The hope is for the formula - that contains common ingredient like vitamins B, C and D, folic acid, green tea extract, cod liver oil and other nutraceuticals - to offset some very serious illnesses and ultimately improve quality of life.

It was initially designed back in 2000 and a series of studies published over the last decade and a half have shown the benefits in mice, both normal mice and those specifically bred for such research because they are rapidly, experiencing dramatic declines in cognitive and motor function in a matter of months.

NutritionInsight spoke with associate researcher Jennifer Lemon (pictured, center)  from McMaster University, Canada, who explains what the main discoveries were and what the next steps could be. She says how the mice used in the study had widespread loss of more than 50 percent of their brain cells impacting multiple regions of the brain, the human equivalent of severe Alzheimer’s Disease.

The mice were fed the supplement on small pieces of bagel each day over several months and over time Lemon found that the formula completely eliminated the severe brain cell loss and abolished cognitive decline.

“All the research suggests there is a huge potential to help people suffering from neurological disease,” Lemon tells NutritionInsight.

“The fact that the complex is made up of things that you can buy over the counter - for us it’s been an astonishing experience. We went into this thinking ‘maybe it will work, maybe we’ll get to see something positive’, we had no idea we would see this kind of effectiveness. But I think what it really demonstrates is that if you protect something on a cellular level, it’s not about having one individual component that fixes things.”

“Disease itself and ageing itself is such a complex process and involves so many different mechanisms going wrong, that you need to support as many of them as you can to be able to have an effective intervention.”

“It’s not about the silver bullet of one drug; it has to be a balanced intervention.”

In addition to looking at the major markers of aging, the researchers also discovered that the mice on the supplements experienced enhanced vision and smell (loss of smell is often associated with neurological disease), and improved balance and motor activity.

Do you think this will translate well into humans? “This is ultimately the failure point for so many interventions. The transition from animal model into human has been a huge deal and a major failure point for a lot of things, but I think because we are going after some very fundamental mechanisms that go wrong in cells and that are the same regardless of the species, we will have positive effects.”

A human trial is starting later this year in the US and the team is working on approvals from the FDA, something Lemon says is easier in America compared with Canada.

“We have some collaborators in the US and will be looking how well the supplement works to reduce inflammation in patients who have had brain surgery. A very focused beam of radiation that they use to destroy benign brain tumors that cannot be operated on in any other way. The problem is you get a lot of inflammation in the area as a result and that causes cognitive decline, headaches and other functional issues so we’re going to see if the supplement can actually reduce that brain inflammation.” 

“Alzheimer's patients is a next step as well, so this first one is stage two or three on ethicacy so we will look at normal healthy patients as well just to make sure the way the supplement is formulated is safe and that everybody can take it.”

“And then we will be moving into patients with cognitive issues either alzheimer's or dementia patients, we’re also looking at Parkinson’s, MS and ALS - these are the ones that we are prioritizing.”

Does it have a name? “We just called it a complex dietary supplement for our research paper but we do have a company that has, in the last couple of years been put together by some venture capitalists that are developing a human formulation.”

“There’s been a first version of it that didn’t really have glitches, it was more of a palatability issue on one component so they’ve gone back and re worked it into a version two and that’s what they are manufacturing right now.”

“The fact that we can get this from stuff that you can buy over the counter at the health food store, really suggests that if you design something based on scientific evidence with a very specific purpose in mind, instead of just putting stuff together because it's popular, you can really have a very profound effect on health.”

by Gaynor Selby

Related Articles

Nutrition & Health News

AI: Nuritas explores potential health benefits during Future of Nutrition Summit

13 Dec 2017 --- Biotechnology company Nuritas has innovative plans for using artificial intelligence (AI) to relieve the potential burden of future global health issues. These plans were outlined during its Future of Nutrition Summit held the day before FiE 2017 in Frankfurt, during which Nuritas Commercial Manager Neil Foster outlined the company’s use of AI for data mining for bioactive peptides, specific molecules with “tremendous” health benefits.

Business News

Vitafoods Europe to examine mainstreaming of personalized nutrition

13 Dec 2017 --- One of the major issues to be discussed at Vitafoods Europe 2018 will be how personalized nutrition can break out of its niche and achieve mass market appeal, the organizers of the global nutraceutical event have announced. Advances in genomics and wearable technology have created new opportunities for products tailored to individual consumers. And in a new poll conducted by the organizers, personalized nutrition ranks as one of the most important industry trends for 2018, behind only clean label and scientifically supported health claims.

Business News

Frutarom finalizes AB-Fortis micro-encapsulation technology acquisition

13 Dec 2017 --- Frutarom has acquired AB-Fortis activities, including a patent-protected micro-encapsulation technology that enables delivery of iron with increased biological absorption. Frutarom announced the signing of an agreement with AB-Biotics S.A. of Spain for the acquisition of the activity of AB-Fortis in November.

Business News

Kappa Bioscience moves to expand vitamin K2 presence in US with new appointments

13 Dec 2017 --- Kappa Bioscience AS, maker of K2Vital vitamin K2 MK-7, has appointed Garnet Pigden and New Jersey-based D2C to head-up the continued development of Kappa’s position in the US market. The appointment spans the establishment of strategy, infrastructure, partnerships and key accounts in support of an overall objective of solidifying vitamin K2 in mainstream US markets and channels, according to Kappa.

Nutrition & Health News

Researchers create app to predict and intervene in users' overeating

13 Dec 2017 --- Researchers at Worcester Polytechnic Institute (WPI) and the University of Connecticut (UConn) are collaborating on a smartphone app aimed at helping users manage their overeating challenges in three key ways: by tracking eating patterns, providing interventions and helping change behavior. According to the researchers, the app and its distinctive methodology have shown “tremendous promise” in an early pilot study.

More Articles
URL : http://www.nutritioninsight.com:80/news/key-interview-the-remarkable-anti-ageing-possibilities-for-new-supplement-discovered-by-canadian-researchers.html